Abstract
The alarming growth of obesity has become a world challenge to public health. The epidemic proportions of obesity prevalence stimulated scientific interest in the etiology and the search for therapeutic interventions capable of preventing the co-morbidities associated with it. The non-alcoholic fatty liver disease (NAFLD) comprises a spectrum of progressive liver dysfunction that is close…